Dr. Hosen Kiat, a leading cardiologist and researcher, is redefining heart care through innovation in imaging, integrative medicine, and preventive science.
FDA warns of severe gut inflammation linked to Carvykti, a cancer therapy for multiple myeloma, but maintains its benefits outweigh…
GLP-1 drugs are revolutionizing weight loss—and personal finance. As health improves, Americans are rethinking budgets, spending, and long-term goals.
Drug-related crashes and unsafe weight-loss pills are fueling a public health crisis, prompting experts to call for education, regulation, and…
GLP-1 drugs like Ozempic may alter PET and CT scan readings, leading to potential misinterpretations and unnecessary procedures, researchers warn.
EDN’s founders are redefining wellness with eco-friendly underwear aimed at improving men’s reproductive health by removing synthetic microplastics.
Smithsonian scientists implant a heart monitor in a clouded leopard to study stress, marking a breakthrough in animal care and…
AstraZeneca launches construction on its $4.5B Albemarle plant, set to create 600 jobs and boost Virginia’s growing biotechnology industry.
Dr. Andrew Weil urges reform of the U.S. healthcare system, promoting integrative, prevention-focused care over costly, profit-driven disease management.
Superspreading alters how pathogens evolve, influencing virulence, transmission, and long-term epidemic behavior across diverse host populations.
Starkey’s Omega AI hearing aid uses deep neural networks for smarter sound, health tracking, and long-lasting performance, redefining hearing tech.
AstraZeneca expands its Virginia site to $4.5B, adding 3,600 jobs and advanced AI manufacturing for cancer and obesity drug production.
ALV-J manipulates miR-155 to silence immune proteins TRAF3 and STAT1, revealing a key viral strategy that aids infection and persistence…
Researchers warn that tramadol-antidepressant combinations heighten seizure risk in elderly patients, spotlighting over-medication in nursing homes.
As the FDA weighs Biohaven’s SCA drug approval, patients and investors await a pivotal decision that could reshape rare disease…
Research shows partisan bumper stickers can escalate driver aggression during stressful moments, highlighting safety risks in polarized times.
Surgeons in China successfully transplanted a gene-edited pig liver into a human, a historic step that could transform organ transplant…
ABA’s Kevin Keane says soda makers are tackling obesity through innovation, transparency, and healthier options under the Make America Healthy…
Researchers find that most common drugs may cause lasting gut microbiome changes, highlighting the need for mindful medication and diet…
A new synthetic fish protein prevents ice crystals from forming, preserving frozen foods and medicines during extreme cold storage and…
Sam’s Club launches $499 pricing for Ozempic and Wegovy, expanding access to weight-loss meds and same-day delivery for refrigerated prescriptions.
A new study reveals COVID boosters cut deaths by 64% and hospitalizations by 39%, offering protection across all age groups…
A VA study shows Covid vaccines reduce deaths by 64%, proving especially vital for those over 65 while offering modest…
A new study encodes music into DNA to simulate reverse genetic flow, offering insights into Lamarckian inheritance and artificial evolutionary…
Amazon debuts prescription kiosks at select One Medical clinics in LA, revolutionizing access to medications with instant, on-site dispensing.
A Johns Hopkins study found cancer risks in Louisiana’s “Cancer Alley” up to 11 times higher than EPA estimates, sparking…
Phase 2 results show AlphaMedix hit primary goals with strong responses and tolerability in GEP-NETs, underscoring 212Pb targeted alpha therapy’s…
New research challenges the 50-50 baby gender myth, revealing parents with several boys or girls are more likely to have…
AlphaMedix™ achieved major success in a phase 2 GEP-NET cancer trial, marking a breakthrough in targeted alpha therapy for advanced…
A new study reveals tramadol provides limited relief and higher risks, challenging its role as a safe opioid for managing…
FDA warns of growing risks from gray-market GLP-1 drugs as unregulated Ozempic and Wegovy alternatives raise safety and counterfeit concerns.
Sign in to your account